BeStock  
Markets › Compare › TBPH vs MLTX

TBPH vs MLTX

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
TBPH · Theravance Biopharma(Delisted)$17.03 ▲ 0.00%
MLTX · MoonLake Immunotherapeutics$10.77 ▼ 1.64%

Head to head

MetricTBPHMLTX
Price$17.03$10.77
Change today▲ 0.00%▼ 1.64%
Market cap$884.18M$916.60M
Return, 3 months–-46.0%
Return, year to date–-18.3%
Return, 1 year–+18.4%
P/E (TTM)16.4-2.8
P/B3.12.1
P/E percentile vs own 5y86th90th
Dividend yield––
Revenue growth (YoY, latest qtr)-20.9%–
Net profit growth (YoY)-110.8%-10.3%
Gross margin––
Operating margin9.2%–
Net margin51.6%–
Return on equity20.9%-67.4%
Analyst target vs. price–+220.3%
Analyst buy share–100%
RSI (14)–25
30-day volatility–46.4%
Max drawdown, 1 year–-89.9%
Trend read–Strong downtrend
Analyst consensus–Buy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • MLTX is the largest of the group by market value.
  • MLTX carries the lowest trailing P/E.

Go deeper

Scroll to Top